HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oreal Joins Heavyweights Tackling Sustainable Surfactants With Geno Biotech

Executive Summary

L’Oreal, Kao and Unilever have partnered with Genomatica, Inc. (Geno) to develop sustainable surfactants by replacing feedstocks such as palm oil and fossil fuels with biotech alternatives.

You may also be interested in...



L’Oreal Partners To Develop Fine Fragrances Featuring ‘100% Natural And Pure Scent Extracts’

Cosmo’s extraction technology harnesses the volatile fragrance molecules of flowers, fruits and other natural ingredients using only air, without the need for heating, cooling or chemical solvents used in conventional scent extraction, L’Oreal says. A tuberose extract is first in line for use in a perfume targeted for launch in 2024.

‘The Party Is Over': Green Claims Requirements Among Many Regulatory Changes Coming To EU Cosmetics

Biorius CEO Frédéric Lebreux provided updates on EU Green Deal initiatives including revision of the Cosmetic Products Regulation, as well as regulations in development for green claims and ecodesign, at the Independent Beauty Association’s virtual Technical/Regulatory Forum.

Unilever Targets Sustainable Palm Oil Alternative With $120m Biotech Deal

Unilever PLC partners with biotechnology company Genomatica to fund and scale plant-based alternatives to palm oil for personal care and cleaning products.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153527

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel